OpenAlex
PricingAboutJobs
Log inGet started
Work

Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy

HTML

Year: 1998
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
DOI: 10.1016/s0140-6736(97)11329-0
Authors: Karl Josef Osterziel, Oliver Strohm, Jochen Schuler, Matthias Friedrich, Dankward Hänlein, Roland Willenbrock, Stefan D Anker, Philip A Poole-Wilson, Michael B Ranke, Rainer Dietz
Institutions: Max Delbrück Center, Humboldt-Universität zu Berlin, Charité – Universitätsmedizin Berlin, University Children's Hospital Tübingen, University of Tübingen
Language: English

Topic: Growth Hormone and Insulin-like Growth Factors
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: recombinant human growth hormone, dilated cardiomyopathy, chronic heart failure, left ventricular mass, insulin-like growth factor I, systolic wall stress, left ventricular function, hemodynamics, functional class
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2105144228
FWCI: 25.86
Cites: 35
Cited by: 384
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms